Are you navigating the complex world of bioprocess CMC development and manufacturing in a small biotech company?
Our latest episode is a must-listen! Join us as we sit down with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, who shares invaluable insights on overcoming the unique challenges faced by small biotech firms.
In this episode, we explore:
- The critical communication strategies needed for successful outsourcing to CDMOs.
- How small biotechs can leverage their agility to make fast, impactful decisions.
- The surprising benefits of wearing multiple hats and fostering cross-functional expertise.
Tune in to discover how mastering these areas can help your small biotech thrive and stay ahead in a competitive market.
Don't miss this opportunity to gain practical advice and turn your challenges into advantages!
Connect with Mark Melville:
LinkedIn: https://www.linkedin.com/in/mark-melville-a9a43b2
Next Steps:
Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation